In response to a recent article about an interesting biotechnology stock, a reader recently asked me how to handle the ...

A Race Against Blindness, an Arizona-based nonprofit organization, has awarded a $1 million grant to fund research and clinical trials focused on Bardet-Biedl Syndrome 1 (BBS1), a rare genetic ...

Canolfan will consist of a new leisure centre, including a sports hall and fitness studios, plus a 25m swimming pool, a ...

ION-464 is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Parkinson's Disease.

A Race Against Blindness, an Arizona-based nonprofit organization, has awarded a $1 million grant to fund research and clinical trials focused on ...

Hormones do a lot throughout a person’s lifespan. Most people associate hormones with development and sex. Learn about their ...

This tiered approach allows investors to engage at the level they’re most comfortable with, sparking their interest with a ...

The state Department of Employment and Economic Development has awarded a southeastern Minnesota city a $1 million grant to ...

Stroke remains a leading cause of long-term disability, impacting millions of individuals annually. Patients with stroke can experience a variety of ...

Korean biotech firms anticipate significant developments in FDA approvals and clinical trials Innovations in medical research ...

Dendritic cells (DC) offer hope that the treatment of end-stage cancer will become much more successful in the near future.

Fadraciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Pancreatic Cancer.